Associate Professor of Immunology, MD Anderson Cancer Center, The University of Texas
Associate Professor of Immunology, MD Anderson Cancer Center, The University of Texas
Global Product Manager for Stem Cell and 3D Cell Culture
Manager Product Development, Life Sciences, Thermo Fisher Scientific
Researcher, University of Minnesota, Center for Immunology
Sr. Field Applications Scientist, Luminex
PhD Candidate - Fry Lab Department of Immunology University of Colorado
Acting Associate Professor of Medicine, Cedars-Sinai Medical Center
Professor of Medicine, Harvard Medical School
Product Manager, Microcapillary Flow Cytometry, Luminex Corporation
Consultant and Director, Department of Immunology, Mayo Clinic
Assistant Professor, Departments of Surgery and Immunology, University of Pittsburgh, Division of Surgical Oncology Research, UPMC Hillman Cancer Center
Associate Professor, Ronald O. Perelman Department of Dermatology and Pathology; NYU Grossman School of Medicine Member, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health
Technical Sales Specialist, Visiopharm
IP/WB Manager at Fortis Life Sciences
Senior Scientist, MilliporeSigma
Research Assistant Professor, Department of Immunology University of Pittsburgh
Postdoctoral Fellow, Fred Hutchinson Cancer Research Center
Postdoctoral Fellow, Laboratory of Dr. Rimas Orentas, Seattle Children's Research Institute
R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
Product Manager at NanoCellect Biomedical, inc.
Scientist II
Associate Professor of Medicine, University of Iowa
This event is now apart of the Cancer Research & Immuno-Oncology Week Virtual Event Series.
Labroots is pleased to announce the inauguration of the 2nd Annual Event in the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-Oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics. Learn from our experts how immunotherapies can work alone, together, or in combination with other treatments to fight cancer.
This year's event includes the following tracks and topics:
New Advancements in Immuno-Oncology
Emerging Targets for Immuno-Oncology Therapy
Advancing Cancer Immunotherapies to the Clinic
Recent breakthroughs in immuno-oncology research translate into a paradigm shift with regards to attacking advancing cancer. The benefits of immuno-oncology have resulted in long-lasting tumor regression where surgery, radiotherapy, chemotherapy, and targeted therapy proved less effective.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2020 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of Labroots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Immuno-Oncology Virtual Event. Submission is free. Submit your abstract here.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRimmuno to follow the conversation!
Visiopharm® is a world leader in Augmented Pathology™ solutions; that comprise precision pathology and high-throughput pathology for tissue-diagnostics and research. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and ...
See moreSino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...
See moreAt Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic ...
See moreOriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based ...
See moreMillipore Sigma is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis ...
See moreFor over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...
See morePerkinElmer is working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and NGS library preparation solutions they need to rapidly respond to the SARS-CoV-2 challenges both today and tomorrow. To ...
See moreBethyl Laboratories, Inc. has been dedicated to improving lives by supporting scientific discovery through its qualified antibody products and custom services since its founding in 1972. Bethyl has a global reputation for quality, consistency and first-class customer care. Every ...
See moreLunaphore is a Swiss firm born with the vision of bringing -omics like approaches to in-situ tissue analytics for cancer research and diagnostic purposes. Lunaphore develops innovative tissue staining platforms based on a cutting-edge technology, providing high quality results ...
See moreACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents to support the development of target therapeutics. The company employs an application oriented development strategy, with a particular focus on product design, quality control and ...
See moreNanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies for cell based assays. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery ...
See moreChemPartner is a global full-service life science CRO/CDMO with over 18 years of pharmaceutical research experience, evolved from the pure chemistry service provider, focusing on research innovation with global reach. As more and more pharmas and biotech companies look for ...
See moreTullia C. Bruno, PhD, is an Assistant Professor in the Department of Immunology at the University of Pittsburgh and a faculty member in the Tumor Microenvironment Center and the Cancer Immunology and Immunotherapy Program at the UPMC Hillman Cancer Center. She obtained her Ph.D ...
See moreDr. Shannon Oda earned a Ph.D. in Immunology from the University of Colorado Anschutz Medical Campus and completed her postdoctoral training with Dr. Philip Greenberg at the Fred Hutchinson Cancer Research Center. She has received several awards, including the Evergreen Fund ...
See moreDr. Sater is a translational physician scientist (hematologist/oncologist) with special interest in immune therapy of cancer. He leads the Genitourinary Malignancies Branch efforts at understanding the role of cancer immunotherapy on the tumor (immune and non-immune) ...
See more